Featured · Mental Health
The Human and Economic Toll of Treatment-Resistant Depression
In this latest episode of the Health Policy Podcast, Mark Desmarais, a principal at Health Management Associates, and Dr. William Sauvé, Chief Medical Officer at Osmind, discuss the economic and human impacts of treatment-resistant depression (TRD). Desmarais highlights a report indicating that individuals with TRD incur approximately $8,000 more in annual healthcare costs compared to those whose depression is well-managed. The conversation also addresses the challenges in diagnosing and treating TRD, emphasizing the need for timely and aggressive interventions to improve patient outcomes and reduce overall healthcare expenditures.
2026-06-23 · with Mark Desmarais
